Helmerich & Payne
HP
39.64
+0.03
+0.08%
Helmerich & Payne
US · HP
#2288 by market cap
Listed 1970
39.64
+0.03
+0.08%
Live - 5344 symbols - heartbeat 286s ago
· 2026-10-08 07:00
Pre-market
40.21
+1.43%
After-hours
39.64
0.00%
- Market cap
- 3.96B
- P/E (TTM)i
- -28.52
- P/Bi
- 1.54
- EPSi
- -1.66
- Div yieldi
- 2.52%
- 52W posi
- 68%
Reader sentiment
Are you bullish or bearish on HP?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 1.95, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +35.89% YoY
Margins
- Gross margin
- 16.27%
- Operating margin
- 6.20%
- Net margin
- -4.41%
Key ratios & quality
- Enterprise valuei
- 5.84B
- Altman Z-Scorei
- 1.95
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.49B | 2.80B | 1.77B | 1.22B | 2.06B | 2.87B | 2.76B | 3.75B |
| Gross profit | 255.91M | 432.48M | 107.25M | -153.76M | 229.19M | 781.51M | 734.58M | 609.52M |
| Selling & admin expenses | 199.26M | 194.42M | 167.51M | 172.20M | 182.37M | 206.69M | 244.88M | 287.05M |
| Research & development | 18.17M | 27.47M | 21.65M | 21.72M | 26.56M | 30.10M | 40.96M | 34.13M |
| Operating profit | 33.43M | 205.22M | -87.68M | -352.82M | 15.62M | 540.25M | 444.26M | 232.32M |
| Pretax profit | 15.84M | -51.22M | -636.50M | -429.87M | 31.32M | 593.38M | 481.02M | -74.11M |
| Tax | -477.17M | -18.71M | -140.11M | -103.72M | 24.37M | 159.28M | 136.86M | 85.84M |
| Net profit | 482.67M | -33.66M | -494.50M | -326.15M | 6.95M | 434.10M | 344.17M | -159.95M |
| Basic EPS | 4 | 0 | -5 | -3 | 0 | 4 | 3 | -2 |
| Diluted EPS | 4.37 | -0.34 | -4.60 | -3.04 | 0.05 | 4.16 | 3.43 | -1.66 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.02B | 1.04B | 1.01B | 1.02B | 932.36M | 1.03B |
| Gross profit | 156.73M | 157.21M | 128.28M | 152.33M | 90.45M | 168.98M |
| Selling & admin expenses | 80.80M | 65.51M | 77.65M | 70.44M | 71.08M | 65.85M |
| Research & development | 9.42M | 7.78M | 7.57M | 6.65M | 7.02M | 5.91M |
| Operating profit | 63.02M | 52.87M | 22.75M | 43.98M | -12.45M | 66.32M |
| Pretax profit | 44.45M | -132.91M | -62.07M | -83.73M | -46.56M | 150.52M |
| Tax | 41.46M | 28.99M | -6.27M | 11.20M | 9.30M | 72.36M |
| Net profit | 2.99M | -161.90M | -55.81M | -94.93M | -55.86M | 78.16M |
| Basic EPS | 0 | -2 | -1 | -1 | -1 | 1 |
| Diluted EPS | 0.01 | -1.64 | -0.58 | -0.98 | -0.59 | 0.74 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.12B | 1.12B | 963.33M | 1.59B | 1.00B | 1.01B | 1.19B | 1.47B |
| Cash & ST investments | 325.82M | 400.90M | 577.22M | 1.12B | 349.23M | 350.77M | 510.26M | 218.34M |
| Inventory | 158.13M | 149.65M | 104.18M | 84.06M | 87.96M | 94.23M | 117.88M | 324.33M |
| Total assets | 6.21B | 5.84B | 4.83B | 5.03B | 4.36B | 4.38B | 5.78B | 6.71B |
| Total current liabilities | 377.17M | 410.24M | 219.14M | 866.31M | 394.81M | 418.93M | 446.95M | 814.84M |
| Short-term debt | -- | -- | 11.36M | 496.11M | 12.38M | 13.77M | 17.00M | 42.82M |
| Long-term debt | 493.97M | 479.36M | 480.73M | 542.00M | 542.61M | 545.14M | 1.78B | 2.06B |
| Total liabilities | 1,832,132,000.00 | 1,827,292,000.00 | 1,511,107,000.00 | 2,121,510,000.00 | 1,590,059,000.00 | 1,610,013,000.00 | 2,864,746,000.00 | 3,876,400,000.00 |
| Total equity | 4.38B | 4.01B | 3.32B | 2.91B | 2.77B | 2.77B | 2.92B | 2.83B |
| Retained earnings | 4.03B | 3.71B | 3.01B | 2.57B | 2.47B | 2.71B | 2.88B | 2.62B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.49B | 1.49B | 1.47B | 1.46B | 1.47B | 1.57B |
| Cash & ST investments | 195.58M | 187.40M | 218.34M | 268.97M | 199.15M | 231.39M |
| Inventory | 321.62M | 329.99M | 324.33M | 324.81M | 330.54M | 325.80M |
| Total assets | 7.24B | 6.86B | 6.71B | 6.46B | 6.34B | 6.29B |
| Total current liabilities | 887.57M | 809.77M | 814.84M | 721.85M | 863.31M | 800.49M |
| Short-term debt | 6.76M | 6.86M | 42.82M | 6.86M | 146.26M | 6.86M |
| Long-term debt | 2.23B | 2.18B | 2.06B | 2.03B | 1.86B | 1.86B |
| Total liabilities | 4,190,000,000.00 | 3,995,276,000.00 | 3,876,400,000.00 | 3,756,820,000.00 | 3,706,410,000.00 | 3,616,365,000.00 |
| Total equity | 3.05B | 2.87B | 2.83B | 2.70B | 2.63B | 2.67B |
| Retained earnings | 2.89B | 2.70B | 2.62B | 2.50B | 2.41B | 2.46B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 557.85M | 855.75M | 538.88M | 136.44M | 233.91M | 833.68M | 684.66M | 542.95M |
| Depreciation & amortization | 583.80M | 562.80M | 481.89M | 419.73M | 403.17M | 382.31M | 397.34M | 625.09M |
| Free cash flow | 91.27M | 397.35M | 398.09M | 54.29M | -38.63M | 438.22M | 189.59M | 116.58M |
| Dividends paid | -308.43M | -313.42M | -260.34M | -109.13M | -107.40M | -201.46M | -168.46M | -100.74M |
| Stock buybacks / issuance | 0 | -42.78M | -28.51M | 0 | -77.00M | -247.21M | -51.30M | 0 |
| Ending cash balance | 326.19M | 382.97M | 536.75M | 936.72M | 269.01M | 316.24M | 1.53B | 225.90M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 56.05M | 121.60M | 206.95M | 182.43M | 36.58M | 153.67M |
| Depreciation & amortization | 157.66M | 179.49M | 188.86M | 181.92M | 180.73M | 180.96M |
| Free cash flow | -102.70M | 24.60M | 142.81M | 114.86M | -26.28M | 83.90M |
| Dividends paid | -25.31M | -25.21M | -25.20M | -25.24M | -25.42M | -25.42M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 245.05M | 227.13M | 225.90M | 279.51M | 204.03M | 239.31M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 11.19 | -0.88 | -13.56 | -10.47 | 0.19 | 15.47 | 11.93 | -5.85 |
| ROA %i | 7.56 | -0.61 | -9.32 | -6.61 | 0.12 | 9.80 | 6.68 | -2.64 |
| ROIC %i | 10.28 | -0.57 | -11.59 | -8.06 | 0.17 | 12.50 | 8.12 | -2.29 |
| 5-year avg ROE %i | 6.11 | 2.94 | -1.48 | -3.33 | -2.70 | -1.84 | 0.70 | 2.25 |
| EBIT margin %i | 1.61 | -0.93 | -34.50 | -34.24 | 2.43 | 21.26 | 18.51 | 0.90 |
| FCF / sales %i | 3.13 | 14.20 | 22.44 | 4.46 | -- | 15.26 | 6.88 | 3.11 |
| Current ratioi | 2.96 | 2.72 | 4.40 | 1.83 | 2.54 | 2.40 | 2.67 | 1.80 |
| Quick ratioi | 2.36 | 2.19 | 3.52 | 1.56 | 2.09 | 1.88 | 2.10 | 1.24 |
| Debt / assetsi | 7.95 | 8.21 | 10.89 | 21.37 | 13.37 | 13.69 | 32.15 | 32.96 |
| LT debt / equityi | 11.27 | 11.95 | 15.51 | 19.91 | 20.61 | 21.15 | 63.14 | 79.54 |
| Interest coveragei | 1.65 | -1.03 | -25.01 | -17.42 | 2.61 | 35.33 | 17.53 | 0.31 |
| Revenue CAGR (3Y) %i | -7.69 | 19.88 | -0.57 | -21.17 | -9.72 | 17.43 | 31.27 | 22.08 |
| Net income CAGR (3Y) %i | 4.71 | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -32.53 | -7.21 | -- | -15.90 | -- | 3.25 | 51.71 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 7.58 | -1.17 | -5.85 | -11.40 | -13.80 | -5.20 |
| ROA %i | 3.73 | -0.58 | -2.64 | -5.15 | -5.55 | -2.11 |
| ROIC %i | 5.36 | 0.14 | -2.29 | -5.24 | -6.56 | -1.76 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 13.96 | 5.84 | 0.90 | -3.01 | -5.41 | 1.55 |
| FCF / sales %i | 2.43 | 1.07 | 3.11 | 4.40 | 6.40 | 7.89 |
| Current ratioi | 1.68 | 1.84 | 1.80 | 2.03 | 1.71 | 1.96 |
| Quick ratioi | 1.11 | 1.20 | 1.24 | 1.38 | 1.17 | 1.38 |
| Debt / assetsi | 30.93 | 31.94 | 32.96 | 31.48 | 31.60 | 29.62 |
| LT debt / equityi | 76.10 | 79.05 | 79.54 | 77.85 | 73.40 | 72.07 |
| Interest coveragei | 6.06 | 2.09 | 0.31 | -1.11 | -2.00 | 0.60 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- North America Solutions is the largest reported line at 55.48% of revenue, across 5 reported segments.
- International Solutions follows at 23.42%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
North America Solutions55.48%
International Solutions23.42%
Offshore Solutions18.38%
All other revenues5.21%
Quote time 2026-10-08 07:00:09 · For reference only, not investment advice and not tailored to your situation.